Utah Medical Prod (UTMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,788 | 7,165 | 5,380 | 3,497 | 1,712 |
| Depreciation Amortization | 259 | 1,172 | 904 | 624 | 311 |
| Income taxes - deferred | -188 | 108 | -77 | -235 | -154 |
| Accounts receivable | -62 | 577 | 246 | 251 | -2 |
| Accounts payable and accrued liabilities | 88 | 154 | 133 | 45 | 165 |
| Other Working Capital | 275 | -161 | -52 | -268 | 80 |
| Other Operating Activity | -16 | -359 | -153 | -134 | -68 |
| Operating Cash Flow | $2,144 | $8,656 | $6,381 | $3,780 | $2,044 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -101 | -517 | -349 | -300 | -197 |
| Investing Cash Flow | $-101 | $-517 | $-349 | $-300 | $-197 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 4,956 | N/A | N/A | N/A |
| Debt Repayment | -1,998 | -2,501 | -2,501 | -2,501 | -1,601 |
| Common Stock Issued | 157 | 1,113 | 645 | 455 | 299 |
| Common Stock Repurchased | -220 | -11,818 | -2,727 | -995 | -804 |
| Other Financing Activity | 0 | 0 | 1 | 0 | 0 |
| Financing Cash Flow | $-2,061 | $-8,250 | $-4,582 | $-3,041 | $-2,106 |
| Exchange Rate Effect | 5 | 26 | 13 | 14 | -1 |
| Beginning Cash Position | 285 | 370 | 370 | 370 | 370 |
| End Cash Position | 272 | 285 | 1,833 | 823 | 110 |
| Net Cash Flow | $-13 | $-85 | $1,463 | $453 | $-260 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,144 | 8,656 | 6,381 | 3,780 | 2,044 |
| Capital Expenditure | -101 | -517 | -349 | -300 | -197 |
| Free Cash Flow | 2,043 | 8,139 | 6,032 | 3,480 | 1,847 |